FindTrial
Sign In

Effectiveness of multiple doses of intermittent preventive treatment with Sulphadoxine-Pyrimethamine by directly observed therapy versus none directly observed therapy in parturient at Jos University Teaching Hospital.

Effectiveness of multiple doses of intermittent preventive treatment with Sulphadoxine-Pyrimethamine by directly observed therapy versus none directly observed therapy in parturient at Jos University Teaching Hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202408866715915
Enrollment
112
Registered
2024-08-02
Start date
2024-05-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Interventions

Use of sulphadoxine pyrimethamine as directly observed therapy for pregnant women according to WHO
Prescription of Sulphadoxine Pyrimethamine for pregnant women

Sponsors

Akor Andrew Onogwu
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Attends the antenatal clinic at Jos University Teaching Hospital 2. >18 years old 3. Has an uncomplicated singleton term pregnancy

Exclusion criteria

Exclusion criteria: 1. Mothers with multiple gestation and sickle cell disease 2. Women with chronic illness such as hypertension, diabetes mellitus, etc. 3. Patients that react to sulphur containing drugs 4. Preterm (<37 wks) labour and delivery 5. Anaemia

Design outcomes

Primary

MeasureTime frame
Maternal malaria parasitemia and packed cell volume at time of delivery will be the primary outcome measure.—

Secondary

MeasureTime frame
The secondary outcome measure will be cord malaria parasitaemia, fetal birth weight and how frequent pregnant women have clinical malaria despite use of Sulphadoxine-Pyrimethamine—

Countries

Nigeria

Contacts

Public ContactAken Alade

Senior Registrar

aken4life@gmail.com+23408069484633

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026